Study of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects by Epicutaneous Allergen Administration

NCT00719511 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

132

Enrollment

OTHER

Sponsor class

Conditions

Allergies

Interventions

DRUG: Purified allergen dose 1 integrated in a Patch system
DRUG: Purified allergen dose 2 integrated in a Patch system
DRUG: Purified allergen dose 3 integrated in a Patch system
DRUG: Purified allergen integrated in a Patch system

Sponsor

University of Zurich